Barriers to the effective implementation of One health policies against AMR in the EU

Funded by the EU4Health 2021 Programme, Tetra Tech conducted a study for the European Commission on the “Barriers to the effective implementation of policies against antimicrobial resistance (AMR)” in the EU Member States, Norway and Iceland. The study provides input to support the EU's overall...

Full description

Bibliographic Details
Published in:European Journal of Public Health
Main Authors: Dates, M, Davies, M
Format: Text
Language:English
Published: Oxford University Press 2023
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595675/
https://doi.org/10.1093/eurpub/ckad160.085
id ftpubmed:oai:pubmedcentral.nih.gov:10595675
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:10595675 2023-11-12T04:19:31+01:00 Barriers to the effective implementation of One health policies against AMR in the EU Dates, M Davies, M 2023-10-24 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595675/ https://doi.org/10.1093/eurpub/ckad160.085 en eng Oxford University Press http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595675/ http://dx.doi.org/10.1093/eurpub/ckad160.085 © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Eur J Public Health Parallel Programme Text 2023 ftpubmed https://doi.org/10.1093/eurpub/ckad160.085 2023-10-29T00:55:12Z Funded by the EU4Health 2021 Programme, Tetra Tech conducted a study for the European Commission on the “Barriers to the effective implementation of policies against antimicrobial resistance (AMR)” in the EU Member States, Norway and Iceland. The study provides input to support the EU's overall goal to combat AMR by improving the development and implementation of One Health national action plans (NAPs) which, in turn, shall contain effective measures in infection prevention and control and prudent use of antimicrobials. The research was conducted under the following study areas: development and implementation of One Health NAPs, infection prevention and control (IPC) measures in hospitals and long-term care facilities (LTCFs); antimicrobial stewardship measures (AMS) in hospitals, LTCFs, primary care and pharmacies. The research revealed some common problems across all countries, such as insufficient funding to deliver on the measures foreseen in the NAPs, the shortages of qualified staff at all levels of care, the lack of measures targeting LTCFs specifically, the limited involvement of pharmacies in AMS, and the disruptions caused by the COVID-19 pandemic in the health sector. The barriers affect each country differently but they are nevertheless common to all, independently of their size and socio-economic situation. Limitations to deliver on the NAPs objectives were also due to lack of other resources besides funding and staff: old infrastructure, insufficient material and equipment, as well as testing capacity, inadequate information systems. Other barriers identified include: limited political focus and awareness of the challenges brought by AMR; lack of operational plans for delivering on the NAPs; lack of harmonised indicators for monitoring the implementation of plans; limited coverage of AMR, AMS and IPC in education and training; and limited public awareness of AMR. KEY MESSAGES: • Countries face common barriers to the effective implementation of One health policies against AMR, such as lack of ... Text Iceland PubMed Central (PMC) European Journal of Public Health 33 Supplement_2
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Parallel Programme
spellingShingle Parallel Programme
Dates, M
Davies, M
Barriers to the effective implementation of One health policies against AMR in the EU
topic_facet Parallel Programme
description Funded by the EU4Health 2021 Programme, Tetra Tech conducted a study for the European Commission on the “Barriers to the effective implementation of policies against antimicrobial resistance (AMR)” in the EU Member States, Norway and Iceland. The study provides input to support the EU's overall goal to combat AMR by improving the development and implementation of One Health national action plans (NAPs) which, in turn, shall contain effective measures in infection prevention and control and prudent use of antimicrobials. The research was conducted under the following study areas: development and implementation of One Health NAPs, infection prevention and control (IPC) measures in hospitals and long-term care facilities (LTCFs); antimicrobial stewardship measures (AMS) in hospitals, LTCFs, primary care and pharmacies. The research revealed some common problems across all countries, such as insufficient funding to deliver on the measures foreseen in the NAPs, the shortages of qualified staff at all levels of care, the lack of measures targeting LTCFs specifically, the limited involvement of pharmacies in AMS, and the disruptions caused by the COVID-19 pandemic in the health sector. The barriers affect each country differently but they are nevertheless common to all, independently of their size and socio-economic situation. Limitations to deliver on the NAPs objectives were also due to lack of other resources besides funding and staff: old infrastructure, insufficient material and equipment, as well as testing capacity, inadequate information systems. Other barriers identified include: limited political focus and awareness of the challenges brought by AMR; lack of operational plans for delivering on the NAPs; lack of harmonised indicators for monitoring the implementation of plans; limited coverage of AMR, AMS and IPC in education and training; and limited public awareness of AMR. KEY MESSAGES: • Countries face common barriers to the effective implementation of One health policies against AMR, such as lack of ...
format Text
author Dates, M
Davies, M
author_facet Dates, M
Davies, M
author_sort Dates, M
title Barriers to the effective implementation of One health policies against AMR in the EU
title_short Barriers to the effective implementation of One health policies against AMR in the EU
title_full Barriers to the effective implementation of One health policies against AMR in the EU
title_fullStr Barriers to the effective implementation of One health policies against AMR in the EU
title_full_unstemmed Barriers to the effective implementation of One health policies against AMR in the EU
title_sort barriers to the effective implementation of one health policies against amr in the eu
publisher Oxford University Press
publishDate 2023
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595675/
https://doi.org/10.1093/eurpub/ckad160.085
genre Iceland
genre_facet Iceland
op_source Eur J Public Health
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595675/
http://dx.doi.org/10.1093/eurpub/ckad160.085
op_rights © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association.
https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
op_doi https://doi.org/10.1093/eurpub/ckad160.085
container_title European Journal of Public Health
container_volume 33
container_issue Supplement_2
_version_ 1782335916201738240